PHB1 and glioblastoma: Targeting GSCs by genetic deletion or pharmacological inhibition of PHB potently inhibits GBM growth and overcomes the resistance of GBM to radiation treatment, highlighting that PHB blockade synergizes with radiotherapy in GBM treatment.